Neonatal stem cells: an essential tool for future veterinary practice

Innovative high-tech biotherapies for animal health
Bringing the best of regenerative medicine to as many as possible
Biotherapies developed and manufactured in France in compliance with good practices
A unique know-how in cell therapy
Technologies developed in full compliance with ethics and animal welfare
Précédent
Suivant

Vetbiobank develops neonatal stem cell-based cellular drugs with unique potential to fight  dogs, cats and horses' chronic inflammatory diseases. Whether they are sick, injured or just old, they help restore their quality of life and well-being.

Come and meet Vetbiobank's management team

News

News

Happy birthday !

The Vetbiobank team would like to wish a very happy birthday to "Chaussette" who was one of our first patients who, as part of a clinical trial, received stem cells in 2014 to manage his osteoarthritis of the elbow. 

Read more

Intellectual Property

Vetbiobank deploys its intellectual property protection strategy internationally and expands its patent portfolio with: A regional phase covering high-potential geographical areas and an additional international PCT filing. 

Read more

Events

Events

Meet Vetbiobank at

6th bioproduction congress

30 Sept.-1 Oct. 2021, Lyon, France

« Bioproduction Challenges & Opportunities for Biotherapies ; lessons learned form COVID-19 pandemic »

This event will bring together experts from companies (big pharmas, SME and Startups) and laboratories developing therapeutic candidates as well as leading bioproduction professionals to accelerate therapeutics drugs such as mAbs, vaccines, cell therapy and novel products into commercial manufacturing.

At a Glance

At a Glance

Groupe 5006@2x
0
International
PUBLICATIONS
in 8 years

10
International
PUBLICATIONS
in 8 years

Groupe 5007@2x
0
CLINICAL STUDIES

5
CLINICAL STUDIES

Groupe 5008@2x
0
CLINICAL CASES

1600
TREATMENTS

Groupe 219@2x
1 st
FRENCH PHARMACEUTICAL ESTABLISHMENT
for Veterinary Cellular Therapy

1st
FRENCH PHARMACEUTICAL ESTABLISHMENT
for Veterinary Cellular Therapy

To develop cellular therapies for veterinary use, to improve and lighten the management of chronic inflammatory animal diseases.

Then to produce them industrially in order to make them accessible to as many people as possible.

Our Job

Our Job

Grâce à leur potentiel biologique intact lié à leur jeunesse, les cellules souches néonatales, peuvent agir sur les causes responsables de nombreuses maladies inflammatoires chroniques qui affectent les articulations, l?appareil digestif, la peau, les muqueuses, ? des animaux

Vetbiobank develops its therapeutic innovations in order to bring: 

to animals, treatments that allow

to pet owners, a solution

to veterinarians, a comlementary expertise

For Veterinarians only

For Veterinarians only

Ask your veterinarian for the price of a stem cell injection at his clinic.

Product Pipeline

Range Product Development & optimization Proof of Concept Pilot study Industrialisation /
Manufacturing
Pivotal study Approval Marketing Launch

CANIPREN

VBX-01
Canine osteoarthritis

CA0102
Atopic dermatitis

CA0103
Atopic dermatitis
Chronic
Inflammatory
Bowel
Disease

Range Product Development & optimization Proof of Concept Pilot study Industrialisation /
Manufacturing
Pivotal study Approval Marketing Launch

FELIPREN

FE0101
Gingivostomatitis

FE0102
Chronic kidney
failure

FE0103
Feline arthrosis

Range Product Development & optimization Proof of Concept Pilot study Industrialisation /
Manufacturing
Pivotal study Approval Marketing Launch

EQUIPREN
OMBISTEM

EQ0101
Equine arthrosis